Literature DB >> 6640242

An assessment of long saphenous venography to evaluate the saphenous vein for femoropopliteal bypass.

J G Mosley, A R Manhire, M Raphael, J A Marston.   

Abstract

A long saphenous venogram was performed on a consecutive series of 42 patients (5 bilateral) though in 4 the vein was not satisfactorily demonstrated. In all cases the long saphenous vein was dissected out and its suitability for use for a femoropopliteal bypass compared to the radiological findings. Eleven veins were unusable for a bypass and radiologically these were narrower (mean diameter 2.8 mm) than the veins which functioned satisfactorily (mean diameter 5.0 mm), and had more tributaries (mean 5) than the suitable veins (mean 2). Preoperative venography is a useful technique to identify veins that will be unsuitable for a femoropopliteal bypass and thereby save an unnecessary dissection.

Entities:  

Mesh:

Year:  1983        PMID: 6640242     DOI: 10.1002/bjs.1800701111

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Early experience with B mode ultrasound mapping of the long saphenous vein prior to femorodistal bypass.

Authors:  M D McShane; J Field; J Smallwood; A D Chant
Journal:  Ann R Coll Surg Engl       Date:  1988-05       Impact factor: 1.891

2.  A comparison of preoperative long saphenous phlebography with operative dissection in assessing the suitability of long saphenous vein for use as a bypass graft.

Authors:  K G Burnand; A Senapati; M L Thomas; N L Browse
Journal:  Ann R Coll Surg Engl       Date:  1985-05       Impact factor: 1.891

3.  Mapping of autogenous saphenous veins as an imaging adjunct to peripheral MR angiography in patients with peripheral arterial occlusive disease and peripheral bypass grafting: prospective comparison with ultrasound and intraoperative findings.

Authors:  Ann-Marie Bintu Munda Jah-Kabba; Guido Matthias Kukuk; Dariusch Reza Hadizadeh; Frank Träber; Arne Koscielny; Mustapha Sundifu Kabba; Frauke Verrel; Hans Heinz Schild; Winfried Albert Willinek
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.